All News #Library
Y-mAbs’s Biologics Danyelza Receives Suppl Approval in US
27 Aug 2025 //
FDA
Y-mAbs Therapeutics Naxitamab-gqgk Receives Suppl Approval in the U.S
20 Mar 2024 //
FDA
Y-mAbs Danyelza (Naxitamab-gqgk) Receives Supplemental Approval In US
26 Nov 2020 //
FDA

Market Place
Sourcing Support